James P Shaffer Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for James P Shaffer.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of James P Shaffer. James P Shaffer is EVP & Chief Commercial Officer in CLINICAL DATA INC ($NOVI) and Chief Business Officer in Eiger BioPharmaceuticals, Inc. ($EIGR).
Latest Insider Trading Transactions of James P Shaffer
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 15 2021 | EIGR | Eiger BioPharmaceu ... | Shaffer James P | Chief Business Offi ... | Option Exercise | A | 9.99 | 71,250 | 711,788 | 71,250 | |
| Mar 15 2021 | EIGR | Eiger BioPharmaceu ... | Shaffer James P | Chief Business Offi ... | Grant | A | 0.00 | 11,875 | 0 | 29,296 | 17.4 K to 29.3 K (+68.16 %) |
| Mar 13 2020 | EIGR | Eiger BioPharmaceu ... | Shaffer James P | Chief Business Offi ... | Option Exercise | A | 5.60 | 50,000 | 280,000 | 50,000 | |
| Mar 13 2020 | EIGR | Eiger BioPharmaceu ... | Shaffer James P | Chief Business Offi ... | Grant | A | 7.31 | 1,500 | 10,965 | 15,921 | 14.4 K to 15.9 K (+10.40 %) |
| Sep 06 2019 | EIGR | Eiger BioPharmaceu ... | Shaffer James P | Chief Business Offi ... | Grant | A | 7.95 | 1,500 | 11,921 | 14,421 | 12.9 K to 14.4 K (+11.61 %) |
| Mar 26 2019 | EIGR | Eiger BioPharmaceu ... | Shaffer James P | Chief Business Offi ... | Option Exercise | A | 14.31 | 50,000 | 715,500 | 50,000 | |
| Mar 26 2019 | EIGR | Eiger BioPharmaceu ... | Shaffer James P | Chief Business Offi ... | Grant | A | 7.95 | 1,500 | 11,921 | 12,921 | 11.4 K to 12.9 K (+13.13 %) |
| Mar 26 2019 | EIGR | Eiger BioPharmaceu ... | Shaffer James P | Chief Business Offi ... | Grant | A | 7.95 | 1,500 | 11,921 | 11,421 | 9.9 K to 11.4 K (+15.12 %) |
| Mar 26 2019 | EIGR | Eiger BioPharmaceu ... | Shaffer James P | Chief Business Offi ... | Grant | A | 8.03 | 1,500 | 12,049 | 9,921 | 8.4 K to 9.9 K (+17.81 %) |
| Mar 26 2019 | EIGR | Eiger BioPharmaceu ... | Shaffer James P | Chief Business Offi ... | Grant | A | 9.90 | 1,500 | 14,854 | 8,421 | 6.9 K to 8.4 K (+21.67 %) |
| Mar 26 2019 | EIGR | Eiger BioPharmaceu ... | Shaffer James P | Chief Business Offi ... | Grant | A | 8.20 | 1,301 | 10,671 | 6,921 | 5.6 K to 6.9 K (+23.15 %) |
| Mar 16 2018 | EIGR | Eiger BioPharmaceu ... | Shaffer James P | Chief Business Offi ... | Option Exercise | A | 9.50 | 60,000 | 570,000 | 60,000 | |
| Mar 14 2017 | EIGR | Eiger BioPharmaceu ... | Shaffer James P | Chief Business Offi ... | Option Exercise | A | 11.75 | 40,000 | 470,000 | 40,000 | |
| Aug 19 2016 | EIGR | Eiger BioPharmaceu ... | Shaffer James P | Chief Business Offi ... | Buy | P | 15.70 | 3,125 | 49,063 | 5,620 | 2.5 K to 5.6 K (+125.25 %) |
| Jun 14 2016 | EIGR | Eiger BioPharmaceu ... | Shaffer James P | Chief Business Offi ... | Buy | P | 22.20 | 420 | 9,324 | 2,495 | 2.1 K to 2.5 K (+20.24 %) |
| Jun 14 2016 | EIGR | Eiger BioPharmaceu ... | Shaffer James P | Chief Business Offi ... | Buy | P | 22.17 | 100 | 2,217 | 2,075 | 2 K to 2.1 K (+5.06 %) |
| Jun 14 2016 | EIGR | Eiger BioPharmaceu ... | Shaffer James P | Chief Business Offi ... | Buy | P | 22.16 | 730 | 16,177 | 1,975 | 1.2 K to 2 K (+58.63 %) |
| May 23 2016 | EIGR | Eiger BioPharmaceu ... | Shaffer James P | Chief Business Offi ... | Buy | P | 19.99 | 745 | 14,893 | 1,245 | 500 to 1.2 K (+149.00 %) |
| May 23 2016 | EIGR | Eiger BioPharmaceu ... | Shaffer James P | Chief Business Offi ... | Buy | P | 19.52 | 500 | 9,760 | 500 | 0 to 500 |
| Mar 28 2016 | EIGR | Eiger BioPharmaceu ... | Shaffer James P | Chief Business Offi ... | Option Exercise | A | 15.89 | 60,699 | 964,507 | 60,699 | |
| Aug 03 2010 | NOVI | CLINICAL DATA INC | Shaffer James P | EVP & Chief Commerc ... | Option Exercise | A | 14.91 | 10,000 | 149,100 | 10,000 |
Page: 1